Literature DB >> 26003883

Selection of DNA aptamers against Human Cardiac Troponin I for colorimetric sensor based dot blot application.

Ghamar Soltan Dorraj1, Mohammad Javad Rassaee2, Ali Mohammad Latifi3, Bahram Pishgoo4, Mahmood Tavallaei5.   

Abstract

Troponin T and I are ideal markers which are highly sensitive and specific for myocardial injury and have shown better efficacy than earlier markers. Since aptamers are ssDNA or RNA that bind to a wide variety of target molecules, the purpose of this research was to select an aptamer from a 79bp single-stranded DNA (ssDNA) random library that was used to bind the Human Cardiac Troponin I from a synthetic nucleic acids library by systematic evolution of ligands exponential enrichment (Selex) based on several selection and amplification steps. Human Cardiac Troponin I protein was coated onto the surface of streptavidin magnetic beads to extract specific aptamer from a large and diverse random ssDNA initial oligonucleotide library. As a result, several aptamers were selected and further examined for binding affinity and specificity. Finally TnIApt 23 showed beast affinity in nanomolar range (2.69nM) toward the target protein. A simple and rapid colorimetric detection assay for Human Cardiac Troponin I using the novel and specific aptamer-AuNPs conjugates based on dot blot assay was developed. The detection limit for this protein using aptamer-AuNPs-based assay was found to be 5ng/ml.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA aptamer; Dot blot assay; Gold nanoparticle; Human Cardiac Troponin I; Selex

Mesh:

Substances:

Year:  2015        PMID: 26003883     DOI: 10.1016/j.jbiotec.2015.05.002

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  6 in total

1.  Enhancement of label-free biosensing of cardiac troponin I.

Authors:  Chase Christenson; Kwaku Baryeh; Samad Ahadian; Rohollah Nasiri; Mehmet R Dokmeci; Marcus Goudie; Ali Khademhosseini; Jing Yong Ye
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2020-02-20

2.  An aptasensor for troponin I based on the aggregation-induced electrochemiluminescence of nanoparticles prepared from a cyclometallated iridium(III) complex and poly(4-vinylpyridine-co-styrene) deposited on nitrogen-doped graphene.

Authors:  Mohammad Saremi; Amir Amini; Hamid Heydari
Journal:  Mikrochim Acta       Date:  2019-03-22       Impact factor: 5.833

Review 3.  Aptamers Targeting Cardiac Biomarkers as an Analytical Tool for the Diagnostics of Cardiovascular Diseases: A Review.

Authors:  Natalia Komarova; Olga Panova; Alexey Titov; Alexander Kuznetsov
Journal:  Biomedicines       Date:  2022-05-06

4.  Horseradish peroxidase-triggered direct in situ fluorescent immunoassay platform for sensing cardiac troponin I and SARS-CoV-2 nucleocapsid protein in serum.

Authors:  Jinhua Liu; Guotong Ruan; Wenlin Ma; Yujie Sun; Haidong Yu; Zhihui Xu; Changmin Yu; Hai Li; Cheng-Wu Zhang; Lin Li
Journal:  Biosens Bioelectron       Date:  2021-11-21       Impact factor: 12.545

5.  Paper-based genetic assays with bioconjugated gold nanorods and an automated readout pipeline.

Authors:  Claudia Borri; Sonia Centi; Sofia Chioccioli; Patrizia Bogani; Filippo Micheletti; Marco Gai; Paolo Grandi; Serena Laschi; Francesco Tona; Andrea Barucci; Nicola Zoppetti; Roberto Pini; Fulvio Ratto
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

Review 6.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.